The SPTBN5 gene neuronal migration disorder genetic test is a specialized diagnostic procedure aimed at detecting mutations in the SPTBN5 gene, which have been associated with disorders affecting neuronal migration. Neuronal migration disorders are a group of conditions that occur when nerve cells (neurons) do not move to their correct location in the developing brain during early fetal development. This can lead to a variety of neurological and developmental problems, including intellectual disabilities, epilepsy, and motor disorders.
This test, performed at DNA Labs UAE, uses advanced genetic sequencing technologies to analyze the SPTBN5 gene for any abnormalities that might be linked to these disorders. By identifying specific genetic mutations, healthcare providers can make accurate diagnoses, better understand the condition's prognosis, and in some cases, offer targeted treatments or interventions that can improve patient outcomes.
The cost of the SPTBN5 gene neuronal migration disorder genetic test at DNA Labs UAE is 4400 AED. This price reflects the intricate process of genetic analysis and the expertise required to interpret the results accurately. For families and individuals facing the challenges associated with neuronal migration disorders, this test represents a crucial step towards obtaining a clear diagnosis and the possibility of personalized care planning.
The HSPB8 gene neuronopathy distal hereditary motor type 2A (dHMN2A) genetic test is a specialized diagnostic tool used to identify mutations in the HSPB8 gene, which are associated with distal hereditary motor neuronopathy type 2A. This condition is a rare genetic disorder characterized by progressive weakness and atrophy of the muscles in the hands and feet, often leading to significant disability. The test is crucial for confirming the diagnosis, understanding the inheritance pattern, and guiding management and treatment options for affected individuals.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to look for specific genetic alterations in the HSPB8 gene that are known to cause dHMN2A. This is achieved through advanced genetic sequencing techniques that ensure accuracy and reliability of the results. The cost of the test is 4400 AED, which reflects the comprehensive nature of the genetic analysis and the expertise required to interpret the results.
By identifying the genetic basis of the condition, the test not only helps in confirming the diagnosis but also assists in family planning and provides insights into the prognosis of the disorder. It is a vital tool for healthcare professionals managing patients with suspected dHMN2A, enabling them to offer personalized care and support to individuals and their families affected by this challenging condition.
The HSPB1 Gene Neuronopathy Distal Hereditary Motor Type 2B Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the HSPB1 gene, which are linked to the development of Distal Hereditary Motor Neuronopathy Type 2B (dHMN2B). This condition is a rare genetic disorder characterized by progressive weakness and atrophy of the distal muscles, primarily affecting the lower limbs and, in some cases, the upper limbs. The test is critical for individuals with clinical symptoms suggestive of dHMN2B or those with a family history of the condition, as it provides definitive genetic evidence for accurate diagnosis, prognosis, and potential management strategies.
The genetic test involves collecting a DNA sample, typically through a blood draw, which is then analyzed for specific mutations in the HSPB1 gene known to cause the condition. The result from this test can guide healthcare professionals in developing personalized treatment plans and offer genetic counseling to affected individuals and their families regarding the inheritance patterns and risks for future offspring.
The cost of the HSPB1 Gene Neuronopathy Distal Hereditary Motor Type 2B Genetic Test at DNA Labs UAE is set at 4400 AED. This cost encompasses the technical process of genetic sequencing and the professional analysis required to interpret the results accurately. Given the specialized nature of this test and its significance in the diagnosis and management of dHMN2B, it represents a crucial investment for individuals seeking clarity on their genetic status concerning this rare neurodegenerative condition.
The GARS1 Gene Neuronopathy Distal Hereditary Motor Type 5 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GARS1 gene, which are implicated in the development of Distal Hereditary Motor Neuronopathy Type V (dHMN-V). This condition is a rare genetic disorder characterized by progressive weakness and atrophy of the distal muscles, primarily affecting the limbs. The GARS1 gene plays a crucial role in the development and function of peripheral neurons, and mutations can lead to the disruption of these processes, manifesting in the clinical symptoms of dHMN-V.
The test involves the collection of a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing techniques to detect the presence of mutations in the GARS1 gene. It is a vital tool for clinicians in confirming a diagnosis, allowing for a better understanding of the condition, and facilitating informed decisions regarding management and treatment options.
At DNA Labs UAE, the cost of the GARS1 Gene Neuronopathy Distal Hereditary Motor Type 5 Genetic Test is set at 4400 AED. This price reflects the sophisticated nature of the testing process and the specialized expertise required to interpret the results accurately. For patients and families affected by this condition, the test represents a crucial step towards achieving a definitive diagnosis and accessing appropriate care and support.
The IGHMBP2 gene neuronopathy, also known as Distal Hereditary Motor Neuropathy Type 6 (dHMN-VI), is a rare genetic disorder that primarily affects the peripheral nerves, leading to muscle weakness and atrophy predominantly in the distal limbs. It is caused by mutations in the IGHMBP2 gene, which plays a crucial role in the maintenance and function of motor neurons. The disorder is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this condition, genetic testing is essential. DNA Labs UAE offers a specific genetic test for the IGHMBP2 gene neuronopathy. The test is designed to detect mutations in the IGHMBP2 gene that are responsible for the condition. This precise genetic testing is crucial for the accurate diagnosis of Distal Hereditary Motor Neuropathy Type 6, enabling affected individuals and their families to understand their condition better and to explore potential treatment and management options.
The cost of the IGHMBP2 gene neuronopathy genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the presence of the specific genetic mutations in the IGHMBP2 gene. By choosing to undergo this genetic testing, individuals can gain valuable insights into their genetic makeup, facilitating informed decisions regarding their health and future care plans.
The DCTN1 gene neuronopathy, also known as Distal Hereditary Motor Neuropathy Type 7B (dHMN7B), is a rare genetic disorder characterized by progressive weakness and atrophy of the distal muscles, primarily affecting the lower limbs. It is caused by mutations in the DCTN1 gene, which plays a crucial role in the structure and function of neurons, particularly in the transport of materials within the nerve cells.
To diagnose this condition, a genetic test is available at DNA Labs UAE, which specifically looks for mutations in the DCTN1 gene. The test is essential for confirming the diagnosis, understanding the disease progression, and making informed decisions regarding the management and treatment of the condition. It can also provide valuable information for family planning and the assessment of risk in family members.
The cost of the DCTN1 gene neuronopathy genetic test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or a cheek swab, and its subsequent analysis in the laboratory. The test is conducted with high precision and confidentiality, ensuring accurate results that can significantly impact the management of Distal Hereditary Motor Neuropathy Type 7B.
The DNMT1 Gene Neuropathy Sensor Type 1E Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the DNMT1 gene, which are linked to the development of Hereditary Sensory Neuropathy Type 1E (HSN1E). HSN1E is a rare genetic disorder characterized by sensory loss, muscle weakness, and various neurological impairments that can significantly affect an individual's quality of life. The test involves analyzing the patient's DNA to detect any genetic anomalies within the DNMT1 gene that are known to cause this condition. With a cost of 4400 AED, the test provides crucial information for the accurate diagnosis and management of HSN1E, enabling targeted treatment strategies and genetic counseling for affected individuals and their families. DNA Labs UAE, with its state-of-the-art facilities and expertise in genetic diagnostics, ensures reliable and precise results for patients undergoing this test.
The PMP22 Gene Neuropathy with Liability to Pressure Palsies (HNPP) Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test is specifically designed to identify mutations in the PMP22 gene, which are known to cause HNPP, a condition characterized by recurrent episodes of numbness, tingling, and muscle weakness. These symptoms are typically triggered by minor physical pressures on the nerves, such as leaning on elbows, crossing legs, or carrying heavy objects.
HNPP is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the PMP22 gene can lead to the disorder. The test involves analyzing the patient's DNA, extracted from a blood sample, to look for the specific genetic changes associated with HNPP. It is a critical tool for confirming a diagnosis, especially in individuals who exhibit symptoms of nerve compression and entrapment.
At DNA Labs UAE, the PMP22 Gene Neuropathy with Liability to Pressure Palsies (HNPP) Genetic Test is offered at a cost of 4400 AED. The test is conducted with high precision and accuracy, ensuring reliable results for patients and healthcare providers. Identifying the genetic basis of HNPP can significantly impact the management and treatment of the condition, allowing for personalized care strategies and prevention of further nerve damage through lifestyle adjustments and monitoring.
The BSCL2 Gene Neuropathy Distal Hereditary Motor Type 5A Genetic Test is a specific diagnostic tool available at DNA Labs UAE, designed to identify mutations in the BSCL2 gene, which are associated with Distal Hereditary Motor Neuropathy Type 5A (dHMN-V). This condition is a rare genetic disorder characterized by progressive weakness and atrophy of the distal muscles, primarily affecting the lower limbs and, in some cases, the hands. The test plays a crucial role in confirming the diagnosis, enabling early intervention and management strategies for affected individuals.
Priced at 4400 AED, the test involves analyzing the patient's DNA sample to look for specific genetic alterations in the BSCL2 gene that are known to cause the disorder. The process helps in understanding the genetic basis of the condition, which can be crucial for family planning and determining the risk of passing the mutation to future generations. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, this test represents a significant step forward in the personalized care and management of genetic neuromuscular disorders.
The SCN9A Gene Neuropathy Hereditary Sensory and Autonomic Type 2 Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, designed to detect mutations in the SCN9A gene. These mutations are associated with Hereditary Sensory and Autonomic Neuropathy Type II (HSAN2), a rare genetic disorder characterized by severe impairment of sensory and autonomic nervous system functions. This condition often leads to a loss of pain and temperature sensation, potentially resulting in unnoticed injuries and serious complications.
The test involves analyzing the patient's DNA to identify any genetic alterations in the SCN9A gene, which plays a critical role in the transmission of sensory and autonomic signals. By pinpointing specific mutations, the test can confirm a diagnosis of HSAN2, allowing for a better understanding of the condition and the development of a tailored management plan.
Offered at a cost of 4400 AED, this genetic test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability. It is a crucial tool for families with a history of the disorder, individuals presenting symptoms of sensory and autonomic dysfunction, or those seeking a definitive diagnosis for unexplained sensory issues. With this test, patients and healthcare providers can gain valuable insights into the genetic basis of HSAN2, paving the way for targeted interventions and improved quality of life.
